PLX - Protalix BioTherapeutics Inc.
2.12
-0.030 -1.415%
Share volume: 722,028
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$2.15
-0.03
-0.01%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-14-2024 | 03-17-2025 | 05-09-2025 | 08-14-2025 | 11-13-2025 | 03-18-2026 | |
| Assets | |||||||
| Total Assets | 61.563 M | 73.417 M | 73.892 M | 78.486 M | 82.264 M | 82.346 M | |
| Current Assets | 47.853 M | 60.078 M | 60.514 M | 65.485 M | 66.502 M | 66.673 M | |
| Inventories | 17.199 M | 21.243 M | 19.506 M | 21.131 M | 21.255 M | 25.729 M | |
| Other Current Assets | 1.050 M | 16.166 M | 16.875 M | 17.016 M | 17.175 M | 16.722 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 27.409 M | 19.760 M | 19.458 M | 17.895 M | 13.647 M | 14.680 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.648 M | 4.591 M | 4.725 M | 4.746 M | 4.724 M | 4.879 M | |
| Other Assets | 9.062 M | 8.748 M | 8.653 M | 8.255 M | 11.038 M | 10.794 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 61.563 M | 73.417 M | 73.892 M | 78.486 M | 82.264 M | 82.346 M | |
| Total liabilities | 29.126 M | 30.206 M | 28.684 M | 28.583 M | 29.356 M | 34.116 M | |
| Total current liabilities | 24.220 M | 25.621 M | 24.322 M | 24.091 M | 21.945 M | 26.518 M | |
| Accounts Payable | 22.712 M | 4.533 M | 4.121 M | 6.689 M | 5.375 M | 5.259 M | |
| Other liabilities | 0.000 | 4.026 M | 3.811 M | 0.000 | 0.000 | 6.937 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 4.026 M | 3.811 M | 0.000 | 0.000 | 6.937 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 32.437 M | 43.211 M | 45.208 M | 49.903 M | 52.908 M | 48.230 M | |
| Common stock | 32.437 M | 421.604 M | 45.208 M | 49.903 M | 52.908 M | 433.227 M | |
| Retained earnings | 0.000 | -378.393 M | 0.000 | 0.000 | 0.000 | -384.997 M |